New York Joins 43 Other States in Lawsuit against Generic Drug Manufacturers

May 21st, 2019

This week New York joined 43 other states led by Connecticut Attorney General Willaim Tong in announcing a lawsuit against a total of 20 generic drug manufacturers. The lawsuit alleges that the Defendants’ conduct artificially increased prices to health insurers, taxpayer-funded healthcare programs like Medicare and Medicaid, and individuals who paid and continue to pay inflated prices for their prescription drugs. The complaint alleges that Teva, Sandoz, Mylan, Pfizer and 16 other generic drug manufacturers engaged in a broad, coordinated and systematic conspiracy to fix prices, allocate markets, and rig bids for more than 100 different generic drugs.

Attorney General Letitia James said:

“The evidence shows a multi-year, multi-faceted conspiracy to enrich pharmaceutical companies at the expense of consumers. The scope of the conspiracy is breathtaking, affecting generic drugs that people rely on every day to treat acute and chronic conditions, like diabetes and arthritis. The blatant anticompetitive conduct alleged in the complaint harmed consumers’ health and well-being in multiple way and we intend to hold the wrongdoers accountable.”